David Katz to Treatment Outcome
This is a "connection" page, showing publications David Katz has written about Treatment Outcome.
Connection Strength
0.301
-
Ben-Chetrit E, Bnaya A, Barchad OW, Vedder K, Katz DE. Chloramphenicol treatment revisited - demographics, clinical characteristics, and outcomes of hospitalized patients. Eur J Clin Microbiol Infect Dis. 2024 Aug; 43(8):1667-1671.
Score: 0.111
-
Ben-Chetrit E, Eldaim MA, Bar-Meir M, Dodin M, Katz DE. Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum ?-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia. Int J Antimicrob Agents. 2019 Apr; 53(4):423-428.
Score: 0.075
-
Katz DE, Friedman ND, Ostrovski E, Ravid D, Amrami N, Avivi D, Mengesha B, Zaidenstein R, Lazarovitch T, Dadon M, Marchaim D. Diabetic foot infection in hospitalized adults. J Infect Chemother. 2016 Mar; 22(3):167-73.
Score: 0.062
-
Katz DE, Martone WJ. Community-phenotype-methicillin-resistant Staphylococcus aureus infections: a retrospective chart review of outcomes after treatment with daptomycin. Clin Ther. 2007 Nov; 29(11):2440-7.
Score: 0.035
-
Rehm S, Campion M, Katz DE, Russo R, Boucher HW. Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy. J Antimicrob Chemother. 2009 May; 63(5):1034-42.
Score: 0.010
-
Krige JE, Lindfield K, Friedrich L, Otradovec C, Martone WJ, Katz DE, Tally F. Effectiveness and duration of daptomycin therapy in resolving clinical symptoms in the treatment of complicated skin and skin structure infections. Curr Med Res Opin. 2007 Sep; 23(9):2147-56.
Score: 0.009